Mosolov S
Consort Psychiatr. 2024; 1(2):29-42.
PMID: 39006901
PMC: 11240135.
DOI: 10.17650/2712-7672-2020-1-2-29-42.
Xu Q, Cai M, Ji Y, Ma J, Liu J, Zhao Q
Schizophrenia (Heidelb). 2023; 9(1):53.
PMID: 37644044
PMC: 10465573.
DOI: 10.1038/s41537-023-00389-2.
Oguchi Y, Nakagawa A, Kocha H
Neuropsychopharmacol Rep. 2022; 43(1):146-149.
PMID: 36482878
PMC: 10009410.
DOI: 10.1002/npr2.12308.
Shnayder N, Novitsky M, Neznanov N, Limankin O, Asadullin A, Petrov A
Genes (Basel). 2022; 13(3).
PMID: 35328011
PMC: 8950769.
DOI: 10.3390/genes13030457.
Miura I, Nosaka T, Yabe H, Hagi K
Int J Neuropsychopharmacol. 2020; 24(3):200-215.
PMID: 33151310
PMC: 7968624.
DOI: 10.1093/ijnp/pyaa082.
Psychiatric Diagnoses and Treatment Preceding Schizophrenia in Adolescents Aged 9-17 Years.
Kang-Yi C, Chao B, Teng S, Locke J, Mandell D, Wong Y
Front Psychiatry. 2020; 11:487.
PMID: 32581869
PMC: 7289314.
DOI: 10.3389/fpsyt.2020.00487.
A 2-year longitudinal study of neuropsychological functioning, psychosocial adjustment and rehospitalisation in schizophrenia and major depression.
Annette S, Stephan G, Mueser K, Martin H, Elisabeth R, Ulrich G
Eur Arch Psychiatry Clin Neurosci. 2020; 270(6):699-708.
PMID: 32246196
PMC: 7423783.
DOI: 10.1007/s00406-020-01118-x.
Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder.
Tan X, Seow E, Abdin E, Verma S, Sim K, Chong S
BMC Psychiatry. 2019; 19(1):267.
PMID: 31477079
PMC: 6721340.
DOI: 10.1186/s12888-019-2248-7.
The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.
Belvederi Murri M, Amore M, Calcagno P, Respino M, Marozzi V, Masotti M
Schizophr Bull. 2016; 42(5):1225-33.
PMID: 27069064
PMC: 4988746.
DOI: 10.1093/schbul/sbw040.
The Role of Insight in Moderating the Association Between Depressive Symptoms in People With Schizophrenia and Stigma Among Their Nearest Relatives: A Pilot Study.
Krupchanka D, Katliar M
Schizophr Bull. 2016; 42(3):600-7.
PMID: 26970100
PMC: 4838116.
DOI: 10.1093/schbul/sbw024.
Augmentation with antidepressants in schizophrenia treatment: benefit or risk.
Mao Y, Zhang M
Neuropsychiatr Dis Treat. 2015; 11:701-13.
PMID: 25834445
PMC: 4370910.
DOI: 10.2147/NDT.S62266.
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.
Samsom J, Wong A
Front Psychiatry. 2015; 6:13.
PMID: 25762938
PMC: 4332163.
DOI: 10.3389/fpsyt.2015.00013.
Testing trait depression as a potential clinical domain in schizophrenia.
Chiappelli J, Kochunov P, DeRiso K, Thangavelu K, Sampath H, Muellerklein F
Schizophr Res. 2014; 159(1):243-8.
PMID: 25171855
PMC: 4177287.
DOI: 10.1016/j.schres.2014.08.003.
The effects of aging on insight into illness in schizophrenia: a review.
Gerretsen P, Plitman E, Rajji T, Graff-Guerrero A
Int J Geriatr Psychiatry. 2014; 29(11):1145-61.
PMID: 25055980
PMC: 4472640.
DOI: 10.1002/gps.4154.
Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem.
Cella M, Swan S, Medin E, Reeder C, Wykes T
Psychol Med. 2013; 44(3):469-76.
PMID: 23734941
PMC: 3880064.
DOI: 10.1017/S0033291713001189.
Schizophrenia - insight, depression: a correlation study.
Ampalam P, Deepthi R, Vadaparty P
Indian J Psychol Med. 2012; 34(1):44-8.
PMID: 22661807
PMC: 3361842.
DOI: 10.4103/0253-7176.96158.
Post-psychotic depression in schizophrenics: (a prospective study).
Das P, Kapur R
Indian J Psychiatry. 2011; 22(3):277-82.
PMID: 22058481
PMC: 3013216.
The correlates of the syndrome of depression in schizophrenia.
Tharyan A, Kuruvilla K
Indian J Psychiatry. 2011; 36(2):74-8.
PMID: 21743673
PMC: 2972463.
Managing suicide risk in patients with schizophrenia.
Kasckow J, Felmet K, Zisook S
CNS Drugs. 2011; 25(2):129-43.
PMID: 21254789
PMC: 3056073.
DOI: 10.2165/11586450-000000000-00000.
Psychosis as a disorder of reduced cathectic capacity: Freud's analysis of the Schreber case revisited.
McGlashan T
Schizophr Bull. 2009; 35(3):476-81.
PMID: 19357240
PMC: 2669588.
DOI: 10.1093/schbul/sbp019.